STAT Plus: Pharmalittle: U.S. hands Glaxo and Sanofi $2.1 billion for a Covid-19 vaccine; Moderna director resigns over conflict concerns
The U.S. government’s Operation Warp Speed will provide up to $2.1 billion to Sanofi and GlaxoSmithKline to fund development and manufacturing of their experimental Covid-19 vaccine.
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may
